Xin Su

1.2k total citations
48 papers, 852 citations indexed

About

Xin Su is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xin Su has authored 48 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xin Su's work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Lipid metabolism and disorders (9 papers). Xin Su is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Lipid metabolism and disorders (9 papers). Xin Su collaborates with scholars based in China and Japan. Xin Su's co-authors include Daoquan Peng, Yi Wen Kong, Ye Cheng, Xijie Wu, Dong Chang, Bin Wang, Xiang Chen, Juan Zhang, Guo‐Ming Zhang and Guanzhong Wu and has published in prestigious journals such as Frontiers in Immunology, Biological reviews/Biological reviews of the Cambridge Philosophical Society and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Xin Su

47 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xin Su China	17	227	208	200	170	163	48	852
Sara Lombardi Italy	15	320 1.4×	281 1.4×	160 0.8×	128 0.8×	153 0.9×	30	1.1k
Juan Gabriel Juárez-Rojas Mexico	17	142 0.6×	236 1.1×	231 1.2×	135 0.8×	225 1.4×	67	848
Robert N. Helsley United States	18	334 1.5×	180 0.9×	217 1.1×	189 1.1×	83 0.5×	35	922
Xuemei Gu China	17	390 1.7×	186 0.9×	236 1.2×	167 1.0×	74 0.5×	40	1.0k
Hong Yu China	20	326 1.4×	186 0.9×	189 0.9×	124 0.7×	86 0.5×	67	1.1k
Sang‐Hyun Lee South Korea	20	296 1.3×	160 0.8×	180 0.9×	239 1.4×	191 1.2×	63	973
Lucas Opazo-Ríos Spain	12	347 1.5×	200 1.0×	155 0.8×	101 0.6×	75 0.5×	20	1.0k
Ana Ninić Serbia	17	124 0.5×	154 0.7×	205 1.0×	126 0.7×	115 0.7×	58	714
Jen‐Pi Tsai Taiwan	19	383 1.7×	93 0.4×	182 0.9×	138 0.8×	169 1.0×	101	1.1k
Stefano Ministrini Italy	16	187 0.8×	134 0.6×	188 0.9×	208 1.2×	187 1.1×	59	846

Countries citing papers authored by Xin Su

Since Specialization

Citations

This map shows the geographic impact of Xin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Su more than expected).

Fields of papers citing papers by Xin Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Su. The network helps show where Xin Su may publish in the future.

Co-authorship network of co-authors of Xin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Su. A scholar is included among the top collaborators of Xin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Su. Xin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Shujun, et al.. (2024). The double roles of T cell-mediated immune response in the progression of MASLD. Biomedicine & Pharmacotherapy. 173. 116333–116333. 9 indexed citations

Wang, Sicen, et al.. (2023). Evaluating the association between dietary salt intake and the risk of atrial fibrillation using Mendelian randomization. Frontiers in Nutrition. 10. 1073626–1073626. 4 indexed citations

Cheng, Ye, et al.. (2023). Relationship between inflammatory-related cytokines with aortic dissection. International Immunopharmacology. 122. 110618–110618. 7 indexed citations

Wang, Lilan, Kaimin Wu, Xin Su, et al.. (2023). Transcatheter aortic valve implantation for patients with heyde syndrome: A literature review of case reports. Heliyon. 9(7). e17952–e17952. 3 indexed citations

Feng, Maoxiao, et al.. (2023). From NAFLD to HCC: Advances in noninvasive diagnosis. Biomedicine & Pharmacotherapy. 165. 115028–115028. 7 indexed citations

Luo, Manyu, et al.. (2023). Zinc deficiency increases lung inflammation and fibrosis in obese mice by promoting oxidative stress. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(1). 130518–130518. 4 indexed citations

Su, Xin, et al.. (2022). Hyperlipidemia and hypothyroidism. Clinica Chimica Acta. 527. 61–70. 67 indexed citations

Wu, Xijie, et al.. (2022). IL-38 in modulating hyperlipidemia and its related cardiovascular diseases. International Immunopharmacology. 108. 108876–108876. 26 indexed citations

Su, Xin, Lianglong Chen, Bin Wang, Linjian Chen, & Cuilian Dai. (2021). Emerging roles of sortilin in affecting the metabolism of glucose and lipid profiles. Bosnian Journal of Basic Medical Sciences. 22(3). 340–352. 8 indexed citations

10.

Su, Xin, Ye Cheng, & Dong Chang. (2021). The Important Role of Leptin in Modulating the Risk of Dermatological Diseases. Frontiers in Immunology. 11. 593564–593564. 16 indexed citations

11.

Su, Xin, Guoming Zhang, Ye Cheng, & Bin Wang. (2021). New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases. Molecular Biology Reports. 48(4). 3761–3771. 2 indexed citations

12.

Su, Xin, et al.. (2021). MicroRNA in cardio-metabolic disorders. Clinica Chimica Acta. 518. 134–141. 10 indexed citations

13.

Su, Xin, Ye Cheng, & Bin Wang. (2021). ANGPTL8 in cardio-metabolic diseases. Clinica Chimica Acta. 519. 260–266. 5 indexed citations

14.

Li, Guiyang, et al.. (2020). YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clinica Chimica Acta. 511. 40–46. 23 indexed citations

15.

Su, Xin, Ye Cheng, & Dong Chang. (2020). Lipid-lowering therapy: Guidelines to precision medicine. Clinica Chimica Acta. 514. 66–73. 11 indexed citations

16.

Su, Xin, et al.. (2020). Cholesteryl ester transfer protein inhibitors in precision medicine. Clinica Chimica Acta. 510. 733–740. 10 indexed citations

17.

Su, Xin & Daoquan Peng. (2019). New insight into sortilin in controlling lipid metabolism and the risk of atherogenesis. Biological reviews/Biological reviews of the Cambridge Philosophical Society. 95(1). 232–243. 30 indexed citations

18.

Su, Xin, Yi Wen Kong, & Daoquan Peng. (2018). New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients. Lipids in Health and Disease. 17(1). 174–174. 57 indexed citations

19.

Su, Xin. (2010). Study on dendritic cells and IL-6,IL-12 in the patients with ulcerative colitis. 1 indexed citations

20.

Su, Xin. (2007). Glycometabolism of sulfonylurea compound G004 in vitro and in vivo. Zhongguo xin yao zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact